Sleep Aids Market is estimated to reach $79,851 million by 2022

News provided by

May 08, 2017, 09:16 ET

NEW YORK, May 8, 2017 /PRNewswire/ -- Highlights

· Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023

· Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia.

· Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern.

· The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023.

· The global sleep aids market is segmented based on product, sleep disorder, and geography.

· The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle.

Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia.

Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023.

The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is categorized into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medications segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is classified into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorder. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. The surge in disposable income; increase in awareness about sleep disorders; stressful work issues; enhanced intake of caffeine, tobacco, and alcohol; and technological advancements are expected to boost the sleep aids market growth. However, adverse effects of sleep aids medication in patient with sleep disorders, such as dizziness, diarrhea, constipation, daytime drowsiness; and expiration on sleep drugs patents are expected to hamper the market growth.

KEY MARKET BENEFITS
This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations provided are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product, sleep disorder, and geography.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

KEY PLAYERS PROFILED
Koninklijke Philips N.V.
Merck & Co.
Sanofi
DeVilbiss Healthcare LLC.
Pfizer Inc.
SleepMed Inc.
Cadwell Laboratories Inc.
Compumedics Limited
Natus Medical Incorporated
GlaxoSmithKline plc.
Sleep Aids Market Key Segments

BY PRODUCT
Mattresses & Pillows
Sleep Laboratories
Medications
Prescription-based drugs
OTC drugs
Herbal drugs
Sleep Apnea Devices

BY SLEEP DISORDER
Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Sleep Walking
Other Sleep Disorders

BY GEOGRAPHY
North America
U.S.
Canada
Mexico

Europe
Germany
UK
France
Spain
Rest of Europe

Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific

LAMEA
Brazil
Turkey
Republic of South Africa
Saudi Arabia
Read the full report: http://www.reportlinker.com/p04883729/Sleep-Aids-Market-Global-Opportunity-Analysis-and-Industry-Forecast.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001